Sanofi (NYSE: SNY) is a large market cap stock with a market cap of 106001.84. It is in the Drug Manufacturers – Major industry and sector Healthcare, with a current P/E of 22.23, a forward P/E of 13.54 and EPS of 1.87. At a stock price of 41.01 (-1.35%) it has a dividend yield of 3.99%.
EPS growth for the last five years have been -4.40%, more recently this last year it has grown by 4.10%. The next year growth is going to be about -0.97% and more long-term 7.40% after five years. EPS growth quarter over quarter is -49.40%. Sales growth for the past five years have been 0.50% and sales growth quarter over quarter is -53.70%.
For performance, Sanofi the past week has seen a gain of -1.28%. For the last month performance for Sanofi is -0.53%. While the last quarter is 5.27% and half year, 6.12%. Finally for the year, performance is -19.00%.
The 52-week high for Sanofi, is at -22.27%, and for the 52-week low it comes to a value of 13.57%. The 20-day simple moving average is 0.21% and 0.44% for the 200-day simple moving average.
Volatility for the week is at 1.60%, and for the month it is 1.38%. Sanofi, has a target price of 52.
In terms of debt, long term debt/equity is *TBA, and for total debt/equity Sanofi has *TBA. The gross margin is 68.80%, while operating margin is *TBA, the profit margin is *TBA. The current ratio is *TBA and the quick ratio is *TBA.
Insider ownership is at 16.40%, with instituitional ownership at 9.70%. Sanofi has a payout ratio of *TBA. With the total shares outstanding coming to 2549.96. The shares float is 2307.97, with the float short at 0.23%, with short ratio coming to 2.33.
In terms of returns, the return on assets see Sanofi, get *TBA, with its returns on investment at 6.50%. Return on equity is *TBA. So will the investors see the target price of 52, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.